UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
T Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended: March 31, 2013 or
£ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ________________ to ________________
Commission file number: 0-25426
NATIONAL INSTRUMENTS CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
Delaware (State or other jurisdiction of incorporation or organization) |
|
74-1871327 (I.R.S. Employer Identification Number) |
|
|
|
11500 North MoPac Expressway Austin, Texas |
|
78759 |
(address of principal executive offices) |
|
(zip code) |
Registrant's telephone number, including area code: (512) 338-9119
__________________________
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes T No £
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes T No £
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer TAccelerated filer £Non-accelerated filer £Smaller reporting company £
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes £ No T
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.
Class |
Outstanding at April 29, 2013 |
Common Stock - $0.01 par value |
123,550,677 |
1
NATIONAL INSTRUMENTS CORPORATION
INDEX
|
|
|
|
|
|
|
|
|
Page No. |
||
|
|
|
Item 1 |
Financial Statements: |
|
|
|
|
|
|
|
|
March 31, 2013 (unaudited) and December 31, 2012 |
3 |
|
|
|
|
|
|
|
(unaudited) for the three months ended March 31, 2013 and 2012 |
4 |
|
|
|
|
|
|
|
(unaudited) for the three months ended March 31, 2013 and 2012 |
5 |
|
|
|
|
|
|
|
(unaudited) for the three months ended March 31, 2013 and 2012 |
6 |
|
|
|
|
Notes to Consolidated Financial Statements |
7 |
|
|
|
Item 2 |
Management's Discussion and Analysis of Financial Condition and Results of Operations |
19 |
|
|
|
Item 3 |
27 |
|
|
|
|
Item 4 |
31 |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
Item 1 |
32 |
|
|
|
|
Item 1A |
32 |
|
|
|
|
Item 2 |
40 |
|
|
|
|
Item 4 |
40 |
|
|
|
|
Item 5 |
40 |
|
|
|
|
Item 6 |
41 |
|
|
|
|
|
42 |
2
PART I - FINANCIAL INFORMATION
ITEM 1. Financial Statements
NATIONAL INSTRUMENTS CORPORATION
(in thousands, except share data)
|
|
|
|
|
|
|
March 31, |
|
December 31, |
|
|
2013 |
|
2012 |
Assets |
|
(unaudited) |
|
|
Current assets: |
|
|
|
|
Cash and cash equivalents |
$ |
172,054 |
$ |
161,996 |
Short-term investments |
|
155,251 |
|
173,166 |
Accounts receivable, net |
|
172,123 |
|
187,060 |
Inventories, net |
|
188,591 |
|
169,990 |
Prepaid expenses and other current assets |
|
58,462 |
|
48,009 |
Deferred income taxes, net |
|
28,361 |
|
27,479 |
Total current assets |
|
774,842 |
|
767,700 |
Property and equipment, net |
|
259,123 |
|
249,721 |
Goodwill |
|
146,660 |
|
147,258 |
Intangible assets, net |
|
89,247 |
|
93,913 |
Other long-term assets |
|
28,358 |
|
26,177 |
Total assets |
$ |
1,298,230 |
$ |
1,284,769 |
Liabilities and stockholders' equity |
|
|
|
|
Current liabilities: |
|
|
|
|
Accounts payable |
$ |
66,821 |
$ |
65,080 |
Accrued compensation |
|
26,202 |
|
29,978 |
Deferred revenue - current |
|
94,992 |
|
90,714 |
Accrued expenses and other liabilities |
|
31,977 |
|
34,373 |
Other taxes payable |
|
21,856 |
|
24,811 |
Total current liabilities |
|
241,848 |
|
244,956 |
Deferred income taxes |
|
46,464 |
|
47,630 |
Liability for uncertain tax positions |
|
21,657 |
|
20,920 |
Deferred revenue - long-term |
|
19,944 |
|
20,446 |
Other long-term liabilities |
|
10,556 |
|
11,689 |
Total liabilities |
|
340,469 |
|
345,641 |
Commitments and contingencies |
|
|
|
|
Stockholders' equity: |
|
|
|
|
Preferred stock: par value $0.01; 5,000,000 shares authorized; none issued and outstanding |
|
- |
|
- |
Common stock: par value $0.01; 180,000,000 shares authorized; 123,528,394 and 122,878,690 shares issued and outstanding, respectively |
|
1,235 |
|
1,229 |
Additional paid-in capital |
|
552,510 |
|
532,845 |
Retained earnings |
|
405,622 |
|
404,210 |
Accumulated other comprehensive (loss) income |
|
(1,606) |
|
844 |
Total stockholders’ equity |
|
957,761 |
|
939,128 |
Total liabilities and stockholders’ equity |
$ |
1,298,230 |
$ |
1,284,769 |
The accompanying notes are an integral part of the financial statements.
3
NATIONAL INSTRUMENTS CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share data)
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
||
|
|
March 31, |
||
|
|
2013 |
|
2012 |
|
|
|
|
|
Net sales: |
|
|
|
|
Product |
$ |
265,418 |
$ |
239,335 |
Software maintenance |
|
21,070 |
|
21,798 |
Total net sales |
|
286,488 |
|
261,133 |
|
|
|
|
|
Cost of sales: |
|
|
|
|
Product |
|
68,626 |
|
59,791 |
Software maintenance |
|
1,614 |
|
1,557 |
Total cost of sales |
|
70,240 |
|
61,348 |
|
|
|
|
|
Gross profit |
|
216,248 |
|
199,785 |
|
|
|
|
|
Operating expenses: |
|
|
|
|
Sales and marketing |
|
114,070 |
|
100,052 |
Research and development |
|
61,256 |
|
54,015 |
General and administrative |
|
22,844 |
|
21,374 |
Acquisition related adjustment |
|
(1,316) |
|
- |
Total operating expenses |
|
196,854 |
|
175,441 |
|
|
|
|
|
Operating income |
|
19,394 |
|
24,344 |
|
|
|
|
|
Other income: |
|
|
|
|
Interest income |
|
185 |
|
230 |
Net foreign exchange loss |
|
(1,462) |
|
(888) |
Other income, net |
|
24 |
|
104 |
Income before income taxes |
|
18,141 |
|
23,790 |
(Benefit from) provision for income taxes |
|
(459) |
|
5,148 |
|
|
|
|
|
Net income |
$ |
18,600 |
$ |
18,642 |
|
|
|
|
|
Basic earnings per share |
$ |
0.15 |
$ |
0.15 |
|
|
|
|
|
Weighted average shares outstanding - basic |
|
123,306 |
|
120,908 |
|
|
|
|
|
Diluted earnings per share |
$ |
0.15 |
$ |
0.15 |
|
|
|
|
|
Weighted average shares outstanding - diluted |
|
124,365 |
|
121,972 |
|
|
|
|
|
Dividends declared per share |
$ |
0.14 |
$ |
0.14 |
The accompanying notes are an integral part of these financial statements.
4
NATIONAL INSTRUMENTS CORPORATION
STATEMENT OF CONSOLIDATED COMPREHENSIVE INCOME
(in thousands)
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
||
|
|
March 31, |
||
|
|
2013 |
|
2012 |
|
|
|
|
|
|
|
|
|
|
Net income |
$ |
18,600 |
$ |
18,642 |
Other comprehensive income, before tax and net of reclassification adjustments: |
|
|
|
|
Foreign currency translation adjustment |
|
(2,924) |
|
4,316 |
Unrealized (loss) gain on securities available-for-sale |
|
(442) |
|
1,293 |
Unrealized gain on derivative instruments |
|
2,078 |
|
3,884 |
Other comprehensive (loss) income, before tax |
|
(1,288) |
|
9,493 |
Tax expense related to items of other comprehensive income |
|
1,162 |
|
2,025 |
Other comprehensive (loss) income, net of tax |
|
(2,450) |
|
7,468 |
Comprehensive income |
$ |
16,150 |
$ |
26,110 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these financial statements. |
5
NATIONAL INSTRUMENTS CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
||
|
|
March 31, |
||
|
|
2013 |
|
2012 |
Cash flow from operating activities: |
|
|
|
|
Net income |
$ |
18,600 |
$ |
18,642 |
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
Depreciation and amortization |
|
16,829 |
|
14,115 |
Stock-based compensation |
|
7,134 |
|
6,303 |
Tax benefit from deferred income taxes |
|
(1,902) |
|
(1,567) |
Tax benefit from stock option plans |
|
(459) |
|
(246) |
Changes in operating assets and liabilities: |
|
|
|
|
Accounts receivable |
|
15,115 |
|
1,671 |
Inventories |
|
(18,045) |
|
(8,413) |
Prepaid expenses and other assets |
|
(12,969) |
|
9,468 |
Accounts payable |
|
1,603 |
|
518 |
Deferred revenue |
|
3,776 |
|
5,374 |
Taxes, accrued expenses and other liabilities |
|
(9,200) |
|
(12,361) |
Net cash provided by operating activities |
|
20,482 |
|
33,504 |
|
|
|
|
|
Cash flow from investing activities: |
|
|
|
|
Capital expenditures |
|
(19,094) |
|
(9,054) |
Capitalization of internally developed software |
|
(2,803) |
|
(3,740) |
Additions to other intangibles |
|
(1,418) |
|
(333) |
Purchases of short-term investments |
|
(8,177) |
|
- |
Sales and maturities of short-term investments |
|
26,092 |
|
84,608 |
Net cash (used in) provided by investing activities |
|
(5,400) |
|
71,481 |
|
|
|
|
|
Cash flow from financing activities: |
|
|
|
|
Proceeds from issuance of common stock |
|
11,798 |
|
7,605 |
Dividends paid |
|
(17,281) |
|
(16,934) |
Tax benefit from stock option plans |
|
459 |
|
246 |
Net cash used in financing activities |
|
(5,024) |
|
(9,083) |
|
|
|
|
|
Net change in cash and cash equivalents |
|
10,058 |
|
95,902 |
Cash and cash equivalents at beginning of period |
|
161,996 |
|
142,608 |
Cash and cash equivalents at end of period |
$ |
172,054 |
$ |
238,510 |
The accompanying notes are an integral part of these financial statements.
6
NATIONAL INSTRUMENTS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1 – Basis of presentation
The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2012, included in our annual report on Form 10-K, filed with the Securities and Exchange Commission. In our opinion, the accompanying consolidated financial statements reflect all adjustments (consisting only of normal recurring items) considered necessary to present fairly our financial position at March 31, 2013 and December 31, 2012, the results of our operations, comprehensive income, and cash flows for the three month periods ended March 31, 2013 and March 31, 2012. Operating results for the three month period ended March 31, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States.
Note 2 – Earnings per share
Basic earnings per share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted EPS is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding (if dilutive) during each period. The number of common share equivalents, which include stock options and restricted stock units (“RSUs”), is computed using the treasury stock method.
The reconciliation of the denominators used to calculate basic EPS and diluted EPS for the three months ended March 31, 2013 and 2012, are as follows:
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||
|
(In thousands) |
||
|
(Unaudited) |
||
|
2013 |
|
2012 |
Weighted average shares outstanding-basic |
123,306 |
|
120,908 |
Plus: Common share equivalents |
|
|
|
Stock options, restricted stock units |
1,059 |
|
1,064 |
Weighted average shares outstanding-diluted |
124,365 |
|
121,972 |
Stock awards to acquire 86,800 and 719,200 shares for the three months ended March 31, 2013 and 2012 were excluded in the computations of diluted EPS because the effect of including the stock awards would have been anti-dilutive.
Note 3 – Cash, cash equivalents and short-term investments
The following tables summarize unrealized gains and losses related to our short-term investments designated as available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31, 2013 |
||||||||
(In thousands) |
|
(Unaudited) |
||||||||
|
|
|
|
Gross |
|
Gross |
|
Cumulative |
|
|
|
|
Adjusted Cost |
|
Unrealized Gain |
|
Unrealized Loss |
|
Translation Adjustment |
|
Fair Value |
Cash |
$ |
134,054 |
$ |
- |
$ |
- |
$ |
- |
$ |
134,054 |
Money Market Accounts |
|
38,001 |
|
- |
|
- |
|
- |
|
38,001 |
Municipal bonds |
|
1,432 |
|
2 |
|
- |
|
- |
|
1,434 |
Corporate bonds |
|
17,835 |
|
- |
|
(34) |
|
(2,314) |
|
15,487 |
U.S. treasuries and agencies |
|
119,006 |
|
19 |
|
- |
|
|
|
119,025 |
Foreign government bonds |
|
18,819 |
|
23 |
|
- |
|
(2,450) |
|
16,392 |
Time deposits |
|
2,912 |
|
- |
|
- |
|
- |
|
2,912 |
Cash, cash equivalents, and short-term investments |
$ |
332,059 |
$ |
44 |
$ |
(34) |
$ |
(4,764) |
$ |
327,305 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
As of December 31, 2012 |
||||||||
|
|
|
|
Gross |
|
Gross |
|
Cumulative |
|
|
|
|
Adjusted Cost |
|
Unrealized Gain |
|
Unrealized Loss |
|
Translation Adjustment |
|
Fair Value |
Cash |
$ |
141,340 |
$ |
- |
$ |
- |
$ |
- |
$ |
141,340 |
Money Market Accounts |
|
20,656 |
|
- |
|
- |
|
- |
|
20,656 |
Municipal bonds |
|
1,465 |
|
1 |
|
- |
|
- |
|
1,466 |
Corporate bonds |
|
8,708 |
|
- |
|
(20) |
|
(910) |
|
7,778 |
U.S. treasuries and agencies |
|
135,953 |
|
- |
|
(28) |
|
- |
|
135,925 |
Foreign government bonds |
|
27,947 |
|
57 |
|
- |
|
(2,919) |
|
25,085 |
Time deposits |
|
2,912 |
|
- |
|
- |
|
- |
|
2,912 |
Cash, cash equivalents, and short-term investments |
$ |
338,981 |
$ |
58 |
$ |
(48) |
$ |
(3,829) |
$ |
335,162 |
7
The following tables summarize the contractual maturities of our short-term investments designated as available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31, 2013 |
||
(In thousands) |
|
(Unaudited) |
||
|
|
Adjusted Cost |
|
Fair Value |
Due in less than 1 year |
$ |
58,363 |
$ |
57,222 |
Due in 1 to 5 years |
|
101,641 |
|
98,028 |
Total available-for-sale debt securities |
$ |
160,004 |
$ |
155,250 |
|
|
|
|
|
Due in less than 1 year |
|
Adjusted Cost |
|
Fair Value |
Corporate bonds |
$ |
- |
$ |
- |
U.S. treasuries and agencies |
|
46,476 |
|
46,479 |
Foreign government bonds |
|
8,975 |
|
7,831 |
Time deposits |
|
2,912 |
|
2,912 |
Total available-for-sale debt securities |
$ |
58,363 |
$ |
57,222 |
|
|
|
|
|
Due in 1 to 5 years |
|
Adjusted Cost |
|
Fair Value |
Municipal bonds |
$ |
1,432 |
$ |
1,434 |
Corporate bonds |
|
17,835 |
|
15,487 |
U.S. treasuries and agencies |
|
72,530 |
|
72,546 |
Foreign government bonds |
|
9,844 |
|
8,561 |
Total available-for-sale debt securities |
$ |
101,641 |
$ |
98,028 |
Note 4 – Fair value measurements
We define fair value to be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market that market participants may use when pricing the asset or liability.
We follow a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value measurement is determined based on the lowest level input that is significant to the fair value measurement. The three values of the fair value hierarchy are the following:
Level 1 – Quoted prices in active markets for identical assets or liabilities
Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly
Level 3 – Inputs that are not based on observable market data
Assets and liabilities measured at fair value on a recurring basis are summarized below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at Reporting Date Using |
||||||
(In thousands) |
|
(Unaudited) |
||||||
Description |
|
March 31, 2013 |
|
Quoted Prices in Active Markets for Identical Assets (Level 1) |
|
Significant Other Observable Inputs (Level 2) |
|
Significant Unobservable Inputs (Level 3) |
Assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents available for sale: |
|
|
|
|
|
|
|
|
Money Market Funds |
$ |
38,001 |
$ |
38,001 |
$ |
- |
$ |
- |
U.S. treasuries and agencies |
|
- |
|
- |
|
- |
|
- |
Short-term investments available for sale: |
|
|
|
|
|
|
|
|
Municipal bonds |
|
1,434 |
|
- |
|
1,434 |
|
- |
Corporate bonds |
|
15,487 |
|
- |
|
15,487 |
|
- |
U.S. treasuries and agencies |
|
119,025 |
|
- |
|
119,025 |
|
- |
Foreign government bonds |
|
16,392 |
|
- |
|
16,392 |
|
- |
Time deposits |
|
2,912 |
|
2,912 |
|
- |
|
- |
Derivatives |
|
7,667 |
|
- |
|
7,667 |
|
- |
Total Assets |
$ |
200,918 |
$ |
40,913 |
$ |
160,005 |
$ |
- |
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Derivatives |
$ |
(2,792) |
$ |
- |
$ |
(2,792) |
$ |
- |
Total Liabilities |
$ |
(2,792) |
$ |
- |
$ |
(2,792) |
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
Fair Value Measurements at Reporting Date Using |
||||||
Description |
|
December 31, 2012 |
|
Quoted Prices in Active Markets for Identical Assets (Level 1) |
|
Significant Other Observable Inputs (Level 2) |
|
Significant Unobservable Inputs (Level 3) |
Assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents available for sale: |
|
|
|
|
|
|
|
|
Money Market Funds |
$ |
20,656 |
$ |
20,656 |
$ |
- |
$ |
- |
U.S. Treasuries and Agencies |
|
- |
|
- |
|
- |
|
- |
Short-term investments available for sale: |
|
|
|
|
|
|
|
|
Municipal bonds |
|
1,466 |
|
- |
|
1,466 |
|
- |
Corporate bonds |
|
7,778 |
|
- |
|
7,778 |
|
- |
U.S. treasuries and agencies |
|
135,925 |
|
- |
|
135,925 |
|
- |
Foreign government bonds |
|
25,085 |
|
- |
|
25,085 |
|
- |
Time deposits |
|
2,912 |
|
2,912 |
|
- |
|
- |
Derivatives |
|
4,246 |
|
- |
|
4,246 |
|
- |
Total Assets |
$ |
198,068 |
$ |
23,568 |
$ |
174,500 |
$ |
- |
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Derivatives |
$ |
(2,804) |
$ |
- |
$ |
(2,804) |
$ |
- |
Total Liabilities |
$ |
(2,804) |
$ |
- |
$ |
(2,804) |
$ |
- |
8
We value our available-for-sale short-term investments based on pricing from third party pricing vendors, who may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. We classify all of our fixed income available-for-sale securities as having Level 2 inputs. The valuation techniques used to measure the fair value of our financial instruments having Level 2 inputs were derived from non-binding market consensus prices that are corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques. We believe all of these sources reflect the credit risk associated with each of our available-for-sale short-term investments. Short-term investments available-for-sale consists of debt securities issued by states of the U.S. and political subdivisions of the U.S., corporate debt securities and debt securities issued by U.S. government corporations and agencies as well as debt securities issued by foreign governments. All short-term investments available-for-sale have contractual maturities of less than 24 months.
Derivatives include foreign currency forward and option contracts. Our foreign currency forward contracts are valued using an income approach (Level 2) based on the spot rate less the contract rate multiplied by the notional amount. Our foreign currency option contracts are valued using a market approach based on the quoted market prices which are derived from observable inputs including current and future spot rates, interest rate spreads as well as quoted market prices of similar instruments. We consider counterparty credit risk in the valuation of our derivatives. However, counterparty credit risk did not impact the valuation of our derivatives during the three month period ended March 31, 2013. There were not any transfers in or out of Level 1 or Level 2 during the three month period ended March 31, 2013.
Our foreign government bonds consist of German government sovereign debt denominated in Euro with maximum maturities of 24 months. Our short-term investments do not involve sovereign debt from any other country in Europe.
We did not have any items that were measured at fair value on a nonrecurring basis at March 31, 2013 and December 31, 2012.
The carrying value of net accounts receivable and accounts payable contained in the Consolidated Balance Sheets approximates fair value.
9
Note 5 – Derivative instruments and hedging activities
We recognize all of our derivative instruments as either assets or liabilities in our statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, we designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.
We have operations in over 40 countries. Sales outside of the Americas accounted for approximately 58% and 59% of our revenues during each of the three month periods ended March 31, 2013 and 2012, respectively. Our activities expose us to a variety of market risks, including the effects of changes in foreign currency exchange rates. These financial risks are monitored and managed by us as an integral part of our overall risk management program.
We maintain a foreign currency risk management strategy that uses derivative instruments (foreign currency forward and purchased option contracts) to help protect our earnings and cash flows from fluctuations caused by the volatility in currency exchange rates. Movements in foreign currency exchange rates pose a risk to our operations and competitive position, since exchange rate changes may affect our profitability and cash flow, and the business or pricing strategies of our non-U.S. based competitors.
The vast majority of our foreign sales are denominated in the customers’ local currency. We purchase foreign currency forward and option contracts as hedges of forecasted sales that are denominated in foreign currencies and as hedges of foreign currency denominated receivables. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash inflows resulting from such sales or firm commitments will be adversely affected by changes in exchange rates. We also purchase foreign currency forward contracts as hedges of forecasted expenses that are denominated in foreign currencies. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash outflows resulting from foreign currency operating and cost of revenue expenses will be adversely affected by changes in exchange rates.
We designate foreign currency forward and purchased option contracts as cash flow hedges of forecasted revenues or forecasted expenses. In addition, we hedge our foreign currency denominated balance sheet exposures using foreign currency forward contracts that are not designated as hedging instruments. None of our derivative instruments contain a credit-risk-related contingent feature.
Cash flow hedges
To help protect against the reduction in value caused by a fluctuation in foreign currency exchange rates of forecasted foreign currency cash flows resulting from international sales over the next one to two years, we have instituted a foreign currency cash flow hedging program. We hedge portions of our forecasted revenue and forecasted expenses denominated in foreign currencies with forward and purchased option contracts. For forward contracts, when the dollar strengthens significantly against the foreign currencies, the change in the present value of future foreign currency cash flows may be offset by the change in the fair value of the forward contracts designated as hedges. For option contracts, when the dollar strengthens significantly against the foreign currencies, the change in the present value of future foreign currency cash flows may be offset by the change in the fair value of the option contracts net of the premium paid designated as hedges. Our foreign currency purchased option contracts are purchased “at-the-money” or “out-of-the-money”. We purchase foreign currency forward and option contracts for up to 100% of our forecasted exposures in selected currencies (primarily in Euro, Japanese yen, and Hungarian forint) and limit the duration of these contracts to 40 months or less.
For derivative instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (“OCI”) and reclassified into earnings in the same line item (net sales, operating expenses, or cost of sales) associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings or expenses during the current period and are classified as a component of “net foreign exchange gain (loss)”. Hedge effectiveness of foreign currency forwards and purchased option contracts designated as cash flow hedges are measured by comparing the hedging instrument’s cumulative change in fair value from inception to maturity to the forecasted transaction’s terminal value.
We held forward contracts with the following notional amounts:
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
US Dollar Equivalent |
||
|
|
As of March 31, 2013 |
|
As of December 31, |
|
|
(Unaudited) |
|
2012 |
Euro |
$ |
72,632 |
$ |
84,770 |
Japanese yen |
|
35,257 |
|
42,209 |
Hungarian forint |
|
37,342 |
|
36,005 |
Total forward contracts notional amount |
$ |
145,231 |
$ |
162,984 |
10
The contracts in the foregoing table had contractual maturities of 36 months or less at March 31, 2013 and December 31, 2012.
At March 31, 2013, we expect to reclassify $6.3 million of gains on derivative instruments from accumulated OCI to net sales during the next twelve months when the hedged international sales occur, $1.4 million of losses on derivative instruments from accumulated OCI to cost of sales when the cost of sales are incurred and $781,000 of losses on derivative instruments from accumulated OCI to operating expenses during the next twelve months when the hedged operating expenses occur. Expected amounts are based on derivative valuations at March 31, 2013. Actual results may vary as a result of changes in the corresponding exchange rate subsequent to this date.
We did not record any ineffectiveness from our hedges during the three month periods ended March 31, 2013 and 2012.
Other Derivatives
Other derivatives not designated as hedging instruments consist primarily of foreign currency forward contracts that we use to hedge our foreign denominated net receivable or net payable positions to protect against the change in value caused by a fluctuation in foreign currency exchange rates. We typically attempt to hedge up to 90% of our outstanding foreign denominated net receivables or net payables and typically limit the duration of these foreign currency forward contracts to approximately 120 days. The gain or loss on the derivatives as well as the offsetting gain or loss on the hedge item attributable to the hedged risk is recognized in current earnings under the line item “net foreign exchange loss”. As of March 31, 2013 and December 31, 2012, we held foreign currency forward contracts with a notional amount of $50 million and $69 million, respectively.
The following tables present the fair value of derivative instruments on our Consolidated Balance Sheets and the effect of derivative instruments on our Consolidated Statements of Income.
Fair Values of Derivative Instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Derivatives |
|||||
|
March 31, 2013 |
December 31, 2012 |
||||
(In thousands) |
(Unaudited) |
|
|
|
||
|
|
|
|
|
|
|
|
Balance Sheet Location |
|
Fair Value |
Balance Sheet Location |
|
Fair Value |
Derivatives designated as hedging instruments |
|
|
|
|
|
|
Foreign exchange contracts - ST forwards |
Prepaid expenses and other current assets |
$ |
4,201 |
Prepaid expenses and other current assets |
$ |
2,956 |
|
|
|
|
|
|
|
Foreign exchange contracts - LT forwards |
Other long-term assets |
|
2,517 |
Other long-term assets |
|
1,046 |
Total derivatives designated as hedging instruments |
|
$ |
6,718 |
|
$ |
4,002 |
|
|
|
|
|
|
|
Derivatives not designated as hedging instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange contracts - ST forwards |
Prepaid expenses and other current assets |
$ |
949 |
Prepaid expenses and other current assets |
$ |
244 |
Total derivatives not designated as hedging instruments |
|
$ |
949 |
|
$ |
244 |
|
|
|
|
|
|
|
Total derivatives |
|
$ |
7,667 |
|
$ |
4,246 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liability Derivatives |
|||||
|
March 31, 2013 |
December 31, 2012 |
||||
(In thousands) |
(Unaudited) |
|
|
|
||
|
|
|
|
|
|
|
|
Balance Sheet Location |
|
Fair Value |
Balance Sheet Location |
|
Fair Value |
Derivatives designated as hedging instruments |
|
|
|
|
|
|
Foreign exchange contracts - ST forwards |
Accrued expenses and other liabilities |
$ |
(1,707) |
Accrued expenses and other liabilities |
$ |
(1,292) |
|
|
|
|
|
|
|
Foreign exchange contracts - LT forwards |
Other long-term liabilities |
|
(915) |
Other long-term liabilities |
|
(798) |
Total derivatives designated as hedging instruments |
|
$ |
(2,622) |
|
$ |
(2,090) |
|
|
|
|
|
|
|
Derivatives not designated as hedging instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange contracts - ST forwards |
Accrued expenses and other liabilities |
$ |
(170) |
|
$ |
(714) |
Total derivatives not designated as hedging instruments |
|
$ |
(170) |
|
$ |
(714) |
|
|
|
|
|
|
|
Total derivatives |
|
$ |
(2,792) |
|
$ |
(2,804) |
11
The following tables present the effect of derivative instruments on our Consolidated Statements of Income for three month periods ended March 31, 2013 and 2012, respectively:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2013 |
||||||||
(In thousands) |
||||||||
(Unaudited) |
||||||||
Derivatives in Cash Flow Hedging Relationship |
|
Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) |
Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |
|
Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |
Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion) |
|
Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion) |
Foreign exchange contracts - forwards and options |
$ |
4,263 |
Net sales |
$ |
1,158 |
Net foreign exchange gain (loss) |
$ |
- |
|
|
|
|
|
|
|
|
|
Foreign exchange contracts - forwards and options |
|
(1,427) |
Cost of sales |
|
108 |
Net foreign exchange gain (loss) |
|
- |
|
|
|
|
|
|
|
|
|
Foreign exchange contracts - forwards and options |
|
(758) |
Operating expenses |
|
(1) |
Net foreign exchange gain (loss) |
|
- |
Total |
$ |
2,078 |
|
$ |
1,265 |
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2012 |
||||||||
(In thousands) |
||||||||
(Unaudited) |
||||||||
Derivatives in Cash Flow Hedging Relationship |
|
Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) |
Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |
|
Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |
Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion) |
|
Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion) |
Foreign exchange contracts - forwards and options |
$ |
462 |
Net sales |
$ |
476 |
Net foreign exchange gain (loss) |
$ |
- |
|
|
|
|
|
|
|
|
|
Foreign exchange contracts - forwards and options |
|
2,248 |
Cost of sales |
|
(8) |
Net foreign exchange gain (loss) |
|
- |
|
|
|
|
|
|
|
|
|
Foreign exchange contracts - forwards and options |
|
1,175 |
Operating expenses |
|
55 |
Net foreign exchange gain (loss) |
|
- |
Total |
$ |
3,885 |
|
$ |
523 |
|
$ |
- |
12
|
|
|
|
|
|
(In thousands) |
|
|
|
|
|
Derivatives not Designated as Hedging Instruments |
Location of Gain (Loss) Recognized in Income |
|
Amount of Gain (Loss) Recognized in Income |
|
Amount of Gain (Loss) Recognized in Income |
|
|
|
March 31, 2013 |
|
March 31, 2012 |
|
|
|
(Unaudited) |
|
(Unaudited) |
Foreign exchange contracts - forwards |
Net foreign exchange gain/(loss) |
$ |
1,324 |
$ |
(1,030) |
|
|
|
|
|
|
Total |
|
$ |
1,324 |
$ |
(1,030) |
Note 6 – Inventories
Inventories, net consist of the following:
|
|
|
|
|
|
|
March 31, 2013 |
|
December 31, |
(In thousands) |
|
(Unaudited) |
|
2012 |
|
|
|
|
|
Raw materials |
$ |
88,860 |
$ |
78,244 |
Work-in-process |
|
10,433 |
|
8,566 |
Finished goods |
|
89,298 |
|
83,180 |
|
$ |
188,591 |
$ |
169,990 |
Note 7 – Intangibles
Intangibles at March 31, 2013 and December 31, 2012 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2013 |
|
|
||||||||
(In thousands) |
|
(Unaudited) |
|
December 31, 2012 |
||||||||
|
|
Gross Carrying Amount |
|
Accumulated Amortization |
|
Net Carrying Amount |
|
Gross Carrying Amount |
|
Accumulated Amortization |
|
Net Carrying Amount |
Capitalized software development costs |
$ |
41,970 |
$ |
(21,119) |
$ |
20,851 |
$ |
45,064 |
$ |
(23,450) |
$ |
21,614 |
Acquired technology |
|
88,792 |
|
(44,818) |
|
43,974 |
|
89,876 |
|
(42,562) |
|
47,314 |
Patents |
|
24,407 |
|
(9,827) |
|
14,580 |
|
24,046 |
|
(9,398) |
|
14,648 |
Other |
|
26,006 |
|
(16,164) |
|
9,842 |
|
27,421 |
|
(17,084) |
|
10,337 |
|
$ |
181,175 |
$ |
(91,928) |
$ |
89,247 |
$ |
186,407 |
$ |
(92,494) |
$ |
93,913 |
Software development costs capitalized for the three month periods ended March 31, 2013 and 2012 were $2.9 million and $3.9 million, respectively, and related amortization expense was $3.7 million and $3.6 million, respectively. Capitalized software development costs for the three month periods ended March 31, 2013 and 2012 included costs related to stock based compensation of $140,000 and $178,000, respectively, and the related amounts in the table above are net of fully amortized assets.
Amortization of capitalized software development costs is computed on an individual product basis for those products available for market and is recognized based on the product’s estimated economic life, generally three years. Acquired core technology and intangible assets are amortized over their useful lives, which range from three to eight years. Patents are amortized using the straight-line method over their estimated period of benefit, generally 10 to 17 years. Total intangible assets amortization expenses were $8.4 million and $7.5 million for the three months ended March 31, 2013 and 2012, respectively.
Note 8 – Goodwill
The carrying amount of goodwill as of March 31, 2013, was as follows:
|
|
|
|
|
|
|
|
Amount |
|
|
(In thousands) |
Balance as of December 31, 2012 |
$ |
147,258 |
Purchase price adjustments |
|
(100) |
Foreign currency translation impact |
|
(498) |
Balance as of March 31, 2012 (unaudited) |
$ |
146,660 |
13
The excess purchase price over the fair value of assets acquired is recorded as goodwill. During the first quarter of 2013, we adjusted the purchase price for one of our 2012 acquisitions, which resulted in the reduction of goodwill by $100,000. As we have one operating segment, we allocate goodwill to one reporting unit for goodwill impairment testing. Goodwill is tested for impairment on an annual basis, and between annual tests if indicators of potential impairment exist, using a fair-value-based approach based on the market capitalization of the reporting unit. Our annual impairment test was performed as of February 28, 2013. No impairment of goodwill was identified during 2013 and 2012. Goodwill is deductible for tax purposes in certain jurisdictions.
Note 9 – Income taxes
We account for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are established when necessary to reduce deferred tax assets to amounts which are more likely than not to be realized.
We account for uncertainty in income taxes recognized in our financial statements using prescribed recognition thresholds and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on our tax returns. We had $21.7 million and $20.9 million of unrecognized tax benefits at March 31, 2013 and December 31, 2012, respectively, all of which would affect our effective income tax rate if recognized. We recorded a gross increase in unrecognized tax benefits of $541,000 for the three month period ended March 31, 2013 as a result of tax positions taken during the period. Our continuing policy is to recognize interest and penalties related to income tax matters in income tax expense. As of March 31, 2013, we have approximately $1.4 million accrued for interest related to uncertain tax positions. The tax years 2006 through 2012 remain open to examination by the major taxing jurisdictions to which we are subject.
Our provision for income taxes reflected an effective tax rate of (3)% and 22% for the three month periods ended March 31, 2013 and 2012, respectively. For the three month period ended March 31, 2013, our effective tax rate was lower than the U.S. federal statutory rate of 35% as a result of an enhanced deduction for certain research and development expenses, profits in foreign jurisdictions with reduced income tax rates, the research and development tax credit, and a tax benefit from disqualifying dispositions of equity awards that do not ordinarily result in a tax benefit. For the three month period ended March 31, 2012 our effective tax rate was lower than the U.S. federal statutory rate of 35% as a result of an enhanced deduction for certain research and development expenses and profits in foreign jurisdictions with reduced income tax rates.
Our earnings in Hungary are subject to a statutory tax rate of 19%. The difference between this rate and the statutory U.S. rate of 35% resulted in income tax benefits of $1.7 million and $2.1 million for the three month periods ended March 31, 2013 and 2012, respectively. No countries other than Hungary had a significant impact on our effective tax rate. We have not entered into any advanced pricing or other agreements with the Internal Revenue Service with regard to any foreign jurisdictions.
The tax position of our Hungarian operation continues to benefit from assets created by the restructuring of our operations in Hungary. In addition, our research and development activities in Hungary continue to benefit from a tax law in Hungary that provides for an enhanced deduction for qualified research and development expenses. Partial release of the valuation allowance on assets from the restructuring and the enhanced tax deduction for research expenses resulted in income tax benefits of $2.4 million and $3.1 million for the three month periods ended March 31, 2013 and 2012, respectively.
Earnings from our operations in Malaysia are free of tax under a tax holiday effective January 1, 2013. This tax holiday expires in 2027. If we fail to satisfy the conditions of the tax holiday, this tax benefit may be terminated early. As our Malaysia manufacturing operation is still in a start up phase, the tax holiday did not result in any income tax benefit for the three month period ended March 31, 2013.
Note 10 – Comprehensive income
Our comprehensive income is comprised of net income, foreign currency translation, unrealized gains and losses on forward and option contracts and securities classified as available-for-sale. The accumulated other comprehensive income/(loss), net of tax, as of March 31, 2013 and 2012, consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2013 |
||||||
|
|
(Unaudited) |
||||||
(In thousands) |
|
Currency translation adjustment |
|
Investments |
|
Derivative instruments |
|
Accumulated other comprehensive income |
Balance as of December 31, 2012 |
$ |
208 |
$ |
(620) |
$ |
1,256 |
$ |
844 |
Current-period other comprehensive (loss) income |
|
(2,924) |
|
(442) |
|
3,343 |
|
(23) |
Reclassified from accumulated OCI into income |
|
- |
|
- |
|
(1,265) |
|
(1,265) |
Income tax expense |
|
74 |
|
11 |
|
1,077 |
|
1,162 |
Balance as of March 31, 2013 |
$ |
(2,790) |
$ |
(1,073) |
$ |
2,257 |
$ |
(1,606) |
14
|
|
Three Months Ended March 31, 2012 |
||||||
|
|
(Unaudited) |
||||||
(In thousands) |
|
Currency translation adjustment |
|
Investments |
|
Derivative instruments |
|
Accumulated other comprehensive income |
Balance as of December 31, 2011 |
$ |
(1,543) |
$ |
(664) |
$ |
(1,293) |
$ |
(3,500) |
Current-period other comprehensive income |
|
4,316 |
|
1,293 |
|
4,407 |
|
10,016 |
Reclassified from accumulated OCI into income |
|
- |
|
- |
|
(523) |
|
(523) |
Income tax expense |
|
934 |
|
280 |
|
811 |
|
2,025 |
Balance as of March 31, 2012 |
$ |
1,839 |
$ |
349 |
$ |
1,780 |
$ |
3,968 |
Note 11 – Stock-based compensation plans
Stock option plans
Our stockholders approved the 1994 Incentive Stock Option Plan (the “1994 Plan”) in May 1994. At the time of approval, 13,668,750 shares of our common stock were reserved for issuance under this plan. In 1997, an additional 10,631,250 shares of our common stock were reserved for issuance under this plan, and an additional 1,125,000 shares were reserved for issuance under this plan in 2004. The 1994 Plan terminated in May 2005, except with respect to outstanding awards previously granted thereunder.
Awards under the plan were either incentive stock options within the meaning of Section 422 of the Internal Revenue Code or nonqualified options. The right to purchase shares under the options vests over a five to ten-year period, beginning on the date of grant. Vesting of ten year awards may accelerate based on the Company’s previous year’s earnings and revenue growth but shares cannot accelerate to vest over a period of less than five years. Stock options must be exercised within ten years from date of grant. Stock options were issued with an exercise price which was equal to the market price of our common stock at the grant date. We estimate potential forfeitures of stock grants and adjust compensation cost recorded accordingly. The estimate of forfeitures will be adjusted over the requisite service period to the extent that actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures will be recognized through a cumulative catch-up adjustment in the period of change and will also impact the amount of stock compensation expense to be recognized in future periods. During the three month period ended March 31, 2013, we did not make any changes in accounting principles or methods of estimates related to the 1994 Plan.
Restricted stock plan
Our stockholders approved our 2005 Incentive Plan (the “2005 Plan”) in May 2005. At the time of approval, 4,050,000 shares of our common stock were reserved for issuance under this plan, as well as the number of shares which had been reserved but not issued under the 1994 Plan (our incentive stock option plan which terminated in May 2005), and any shares that returned to the 1994 Plan as a result of termination of options or repurchase of shares issued under such plan. The 2005 Plan, administered by the Compensation Committee of the Board of Directors, provided for granting of incentive awards in the form of restricted stock and RSUs to directors, executive officers and employees of the Company and its subsidiaries. Awards vest over a three, five or ten-year period, beginning on the date of grant. Vesting of ten year awards may accelerate based on the Company’s previous year’s earnings and growth but ten year awards cannot accelerate to vest over a period of less than five years. The 2005 Plan terminated on May 11, 2010, except with respect to outstanding awards previously granted thereunder. There were 3,362,304 shares of common stock that were reserved but not issued under the 1994 Plan and the 2005 Plan as of May 11, 2010.
15
Our stockholders approved our 2010 Incentive Plan (the “2010 Plan”) on May 11, 2010. At the time of approval, 3,000,000 shares of our common stock were reserved for issuance under this plan, as well as the 3,362,304 shares of common stock that were reserved but not issued under the 1994 Plan and the 2005 Plan as of May 11, 2010, and any shares that are returned to the 1994 Plan and the 2005 Plan as a result of forfeiture or termination of options or RSUs or repurchase of shares issued under these plans. The 2010 Plan, administered by the Compensation Committee of the Board of Directors, provides for granting of incentive awards in the form of restricted stock and RSUs to employees, directors and consultants of the Company and employees and consultants of any parent or subsidiary of the Company. Awards vest over a three, five or ten-year period, beginning on the date of grant. Vesting of ten year awards may accelerate based on the Company’s previous year’s earnings and growth but ten year awards cannot accelerate to vest over a period of less than five years. There were 3,844,252 shares available for grant under the 2010 Plan at March 31, 2013.
We estimate potential forfeitures of RSUs and adjust compensation cost recorded accordingly. The estimate of forfeitures will be adjusted over the requisite service period to the extent that actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures will be recognized through a cumulative catch-up adjustment in the period of change and will also impact the amount of stock compensation expense to be recognized in future periods. During the three month period ended March 31, 2013, we did not make any changes in accounting principles or methods of estimates related to the 2010 Plan.
Employee stock purchase plan
Our employee stock purchase plan permits substantially all domestic employees and employees of designated subsidiaries to acquire our common stock at a purchase price of 85% of the lower of the market price at the beginning or the end of the purchase period. The plan has quarterly purchase periods generally beginning on February 1, May 1, August 1 and November 1 of each year. Employees may designate up to 15% of their compensation for the purchase of common stock under this plan. On May 10, 2011, our stockholders approved an additional 3,000,000 shares for issuance under our employee stock purchase plan, and at March 31, 2013, we had 2,246,705 shares of common stock reserved for future issuance under this plan. We issued 340,322 shares under this plan in the three month period ended March 31, 2013. The weighted average purchase price of the employees’ purchase rights was $20.03 per share. During the three months ended March 31, 2013, we did not make any changes in accounting principles or methods of estimates with respect to such plan.
Authorized Preferred Stock and Preferred Stock Purchase Rights Plan
We have 5,000,000 authorized shares of preferred stock. On January 21, 2004, our Board of Directors designated 750,000 of these shares as Series A Participating Preferred Stock in conjunction with its adoption of a Preferred Stock Rights Agreement (the “Rights Agreement”) and declaration of a dividend of one preferred share purchase right (a “Right”) for each share of common stock outstanding held as of May 10, 2004 or issued thereafter. Each Right will entitle its holder to purchase one one-thousandth of a share of National Instruments’ Series A Participating Preferred Stock at an exercise price of $200, subject to adjustment, under certain circumstances. The Rights Agreement was not adopted in response to any effort to acquire control of National Instruments.
The Rights only become exercisable in certain limited circumstances following the tenth day after a person or group announces acquisitions of or tender offers for 20% or more of our common stock. In addition, if an acquirer (subject to certain exclusions for certain current stockholders of National Instruments, an “Acquiring Person”) obtains 20% or more of our common stock, then each Right (other than the Rights owned by an Acquiring Person or its affiliates) will entitle the holder to purchase, for the exercise price, shares of our common stock having a value equal to two times the exercise price. Under certain circumstances, our Board of Directors may redeem the Rights, in whole, but not in part, at a purchase price of $0.01 per Right. The Rights have no voting privileges and are attached to and automatically traded with our common stock until the occurrence of specified trigger events. The Rights will expire on the earlier of May 10, 2014 or the exchange or redemption of the Rights.
There were not any shares of preferred stock issued and outstanding at March 31, 2013.
Note 12 – Segment information
We determine operating segments using the management approach. The management approach designates the internal organization that is used by management for making operating decisions and assessing performance as the source of our operating segments. It also